We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
694
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUMA icon
4051
Humacyte
HUMA
$179M
$36K ﹤0.01%
11,100
-36,000
-76% -$200K
PTIX
4052
DELISTED
Performance Technologies
PTIX
$36K ﹤0.01%
896
-929
-51% -$41.2K
MOTS
4053
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$36K ﹤0.01%
425
+180
+73% +$15K
PDYN icon
4054
Palladyne AI
PDYN
$313M
$35K ﹤0.01%
+2,200
New +$54.6K
SHCR
4055
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$35K ﹤0.01%
+22,300
New +$54.8K
AMS icon
4056
American Shared Hospital Services
AMS
$10.2M
$34K ﹤0.01%
15,300
+3,000
+24% +$6.86K
EQ icon
4057
Equillium
EQ
$138M
$34K ﹤0.01%
+16,500
New +$41.4K
LEXX icon
4058
Lexaria Bioscience
LEXX
$10.1M
$34K ﹤0.01%
+767
New +$30.8K
NXGL icon
4059
NexGel
NXGL
$3.79M
$34K ﹤0.01%
+20,231
New +$32.8K
ATXI
4060
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$34K ﹤0.01%
+111
New +$42.8K
LMNL
4061
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$34K ﹤0.01%
6,640
+3,112
+88% +$20.2K
BRDS
4062
DELISTED
Bird Global, Inc.
BRDS
$34K ﹤0.01%
3,136
+2,640
+532% +$80.4K
PCSA icon
4063
Processa Pharmaceuticals
PCSA
$8.58M
$33K ﹤0.01%
+23
New +$31.5K
AUVI
4064
DELISTED
Applied UV, Inc. Common Stock
AUVI
$33K ﹤0.01%
117
-450
-79% -$86.6K
AIFA
4065
All In FutureTech Alliance Inc
AIFA
$17.7M
$32K ﹤0.01%
+3,700
New +$34.1K
JFIN
4066
Jiayin Group
JFIN
$121M
$32K ﹤0.01%
14,400
-36,700
-72% -$75.4K
SNGX icon
4067
Soligenix
SNGX
$5.78M
$32K ﹤0.01%
220
+69
+46% +$9.54K
EMPD
4068
Empery Digital
EMPD
$76.5M
0
XWEL icon
4069
XWELL
XWEL
$8.7M
$32K ﹤0.01%
2,345
-1,877
-44% -$33K
QTT
4070
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$32K ﹤0.01%
32,980
+12,000
+57% +$13.4K
FABC
4071
Fabric.AI Inc
FABC
$18M
$31K ﹤0.01%
292
-4,292
-94% -$555K
PHGE icon
4072
BiomX
PHGE
$1.6M
$31K ﹤0.01%
222
+96
+76% +$19.7K
SNDL icon
4073
Sundial Growers
SNDL
$313M
$31K ﹤0.01%
9,523
VATE icon
4074
INNOVATE Corp
VATE
$105M
$31K ﹤0.01%
+1,800
New +$49.3K
SONX
4075
DELISTED
Sonendo, Inc.
SONX
$31K ﹤0.01%
+18,089
New +$48.3K

Similar funds

Jim Simons's Q2 2022 Portfolio in Review

As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
  • Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Jim Simons opened 694 new positions and closed 562 in Q2 2022.
  • Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.